Subtype 1 had upregulated PI3K/Akt signaling, MAPK signaling, focal adhesion, ECM-receptor interaction pathways, as well as immune response-related pathways, including cytokine-cytokine receptor interaction, IL-6 signaling, inflammatory response, immunodeficiency, and immunological rejection. This evidence concerns the gene PIK3CA and immune system disorder.